R&I POLICY: SPONSORSHIP FEES
|
|
- Melvyn York
- 7 years ago
- Views:
Transcription
1 R&I POLICY: SPONSORSHIP FEES R&I P02 Main Author(s): Rebecca Smith, Research Operations Manager Consultation Route: R&I Senior Team, NBT Research Committee Original Date of Issue: June 2013 Date of Review: August 2014 Current Version Reviewed By: Rebecca Smith, Research Operations Manager Ratifying Committee: Research Advisory Group Summary of changes: 1. Removal of options for sponsorship costs in section 5. Date of Next Review: August 2016 Version 2.0/August 2014/Page 1 of 7
2 Sponsor Fees: Meeting the costs of undertaking activities to fulfil the role of sponsor for non commercial NHS research at NBT 1. Purpose 1.1. NBT does not currently seek extra funding to cover the costs incurred by sponsorship of non-commercial research. This paper proposes a new policy for recovery of these costs, the criteria and a costing structure for NBT sponsorship of non-commercial research projects. 2. Background 2.1. The costs of undertaking activities to fulfil the role of sponsor 1 for non commercial NHS research are increasing at NBT as NBT take on sponsorship of increasing numbers and increasingly complex research studies. There is increasing financial pressure on NHS trusts and universities to ensure that all funding (clinical and research) is transparent and research costs are all identified and funded appropriately In May 2012 the Department of Health (DH) published new guidelines for Attributing the costs of health & social care Research & Development (AcoRD) 2. The AcoRD guidance supersedes earlier guidance contained in Attributing Revenue Costs of non-commercial research in the NHS (ARCO) and must be used to attribute the costs of research taking place in the NHS from October If NBT is to sponsor a study safely (especially a Clinical Trial of an Investigational Medicinal Product (CTIMP)) and ensure sponsor responsibilities are undertaken appropriately NBT should have appropriately resourced systems in place in order to do so. There should be transparency in how this is resourced In order to produce a policy on sponsorship fees a review of AcoRD and the mechanisms for recouping costs associated with sponsorship of non-commercial research projects used by other organisations is necessary. Sponsor roles and responsibilities 2.5. The sponsor is the individual, or organisation (or group of individuals or organisations) that takes on responsibility for confirming there are proper arrangements to initiate, manage and monitor, and finance a study At NBT we provide the following sponsor services: Contract management - The arrangement, agreement and maintenance of contracts pertaining to the research study including funding contracts, service level agreements, sub-contracts and interparty contracts for delivery and ownership of the research. Study set up advice on protocol design, design and provision of site files and delegation logs 1 Sponsor as defined by Department of Health (2005). Research Governance Framework for Health and Social Care. 2nd edition. 2 Department of Health 2012 Attributing the costs of health & social care Research & Development (AcoRD) Version 2.0/August 2014/Page 2 of 7
3 Monitoring/audit development of monitoring plans, site visits and associated travel costs, attendance at data monitoring committees as necessary Pharmacovigilance including safety reporting Staff training - GCP Archiving Arranged externally at cost Support and advice on delivery of research plus including regulatory approvals and completion of forms (MHRA, REC) 3. Attributing the costs of health & social care Research & Development (AcoRD) 3.1. Sponsor related activities remain classified as research costs in AcoRD. This means that the cost of these activities should be covered by research funding Study specific central trial co-ordination and management, archiving, training and registration of trials should always be included in the grant funding Local trial co-ordination and management, regulatory preparation and compliance (REC, MHRA) and sponsorship fees (MHRA and CTA fees) should also be covered by grant funding except where the funder is a medical research charity that is a member of the Association of Medical Research Charities (AMRC) and the activity is undertaken by existing staff employed by the NHS, NIHR Clinical Research Network or other organisations funded by the NHS to provide patient care services. Under these circumstances, the cost of the activities will be met by DH. The DH funding is in the form of NIHR Research Capability Funding (RCF) already received by the organisation NBT sponsorship services should therefore be categorised as follows: Central trial co-ordination grant funded Staff training grant funding Archiving grant funding Local single site management - grant funded or RCF (where AMRC charity funded) for local site set up Monitoring/audit grant funded or RCF (where AMRC charity funded) Pharmacovigilance grant funding or RCF (where AMRC charity funded) Support and advice grant funded or RCF (where AMRC charity funded) 4. Benchmarking 4.1. A 2010 review of sponsor fees 3 indicated that 30% of those asked charged a sponsor fee. 59% charged a single one off fee, 36% charged a set-up fee and an annual fee and 5% varied their charge dependent on other aspects Key points from the costing structures of those who do charge a fee: Organisations charge a median basic fee of 1000 to sponsor a study. However, a large range of fees are charged ( 50 20,000) as one off or set up fee depending on the type of study. Some charge a flat rate (same fee for any 3 Sponsor Fees: Meeting the costs of undertaking activities to fulfil the role of sponsor for non commercial NHS research Version 2.0/August 2014/Page 3 of 7
4 type of study) and others have a full range of charges for different types of studies On average organisations charge double the basic fee for CTIMPs Although the way fees are charged was different for each organisation it was clear additional fees are charged for CTIMPs/device trials (on average twice the fee than for non CTIMPs). In general, organisations charge the lowest (basic or zero) fees for student research, questionnaire and qualitative research Only four respondents provided details of the annual fees charged in two cases these were the same as the set-up fee (therefore the same fee would be charged each year), in the other two the annual fee was 30-60% of the set-up fee University Hospitals Bristol NHS Foundation Trust (UHBristol) have also been reviewing their sponsor fees policy and have recently commenced testing a range of charges with funding applications. They charge a basic set-up fee and then have additional premiums and annual charges on top for multicentre studies, CTIMPs, contracting and monitoring. NBT R&I Office have been collaborating on the development of a common policy. Version 2.0/August 2014/Page 4 of 7
5 4.4. A summary of sponsor fees charged by organisations charging a one off fee plus UHBristol costs is below: Min Max Mean 4 Median 5 charges UHBristol Basic Fee 50 5,000 1,329 1, Additional premium charged (on top of basic fee): CTIMPs (any) ,608 4,608 1, Student studies (undergrad) Student studies (postgrad) Single centre studies 0 8,304 2, Multicentre studies 0 8,304 2, Observational studies 0 1, Interventional studies 0 8,304 1, Device studies 0 8,304 1, Questionnaire studies Qualitative studies Annual cost single site 138 per site set-up 1208/ 1510 CTIMP Annual cost additional 137/ sites 370 CTIMP Annual monitoring per site 374 Contract set up 82 per site Contracts annual single site 984 Contracts multicentre annual 82 per site 4 Mean is the mathematical average of a set of numbers. It is calculated by adding up two or more scores and dividing the total by the number of scores. 5 Median is found by arranging all the numbers from lowest value to highest value and picking the middle one. The median is often used in preference to the mean, particularly when a distribution is skewed i.e. there are outliers in the dataset that skew the mean. The median is given here as the mean is skewed by one respondent charging considerably higher fees (5 10 times) than all the others. Version 2.0/August 2014/Page 5 of 7
6 5. NBT sponsorship costs 5.1. All research costs should be transparent and funded appropriately and the one off costing does not achieve this NBT will use a project specific cost tool to allocate sponsorship costs against a project that are based around actual costs to sponsor a specific study. This method allows risk and workload to be accounted for providing actual and justifiable costs. The disadvantages are that it is more complex to apply and therefore more time is needed to include it in grant costings. Actual Cost Costing Model Task Cost Unit Basis for cost Study specific central trial coordination and management Contract management across sites 225 per site 2 day Contracts Officer (CO) Green light approval - MHRA approved study (site assessment and set up) 60 per site 5h Governance Officer (GO) Green light approval non-mhra study (site assessment and set up) 30 per site 2.5h GO SIV -MHRA approved study 200 per site 1 day Clinical Trials Officer (CTO) plus travel SIV - non-mhra study 100 per site 1/2 day CTO plus travel Close out 100 per site 1/2 day CTO plus travel Local trial co-ordination and management 0 Regulatory preparation grant staff project Governance and delivery team - MHRA approved study 100 single 4h CTO and 3h GO Governance and delivery team -non- MHRA study 25 single 2h GO Project staff 0 as required Compliance- MHRA approved study Monitoring 460 per site per year 4 days CTO Emergency contact 60 per site per year 4h CTO Safety and compliance reporting 60 per site per year 4h CTO Compliance - non-mhra study Monitoring 115 per site per year 1 day CTO Emergency contact 30 per site per year 2h CTO Version 2.0/August 2014/Page 6 of 7
7 Safety and compliance reporting 30 per site per year 2h CTO Archiving 152 per box Iron Mountain per staff GCP and other research Training 200 member training Trial fees (MHRA, CTA etc) as required Trial registration (ISCRTN etc) as required 5.3. Costs should be allocated according to actual planned activity so if monitoring is not required for a study then the cost of monitoring need not be included. 6. Application of the policy 6.1. This model should be applied to: All studies sponsored by NBT with external funding. Including but not limited to fellowships, staff projects and all other clinical research where a sponsoring organisation is required. The costs to cover actual sponsorship activities should be included in the grant application (see exemptions below). Where costs have not been included in an application, waiver of fee is by application to the R&I Senior Management Team The following exemptions to this policy apply: Studies that are not sponsored by NBT if the funding application is to be submitted by an external organisation (e.g. universities) the sponsoring organisation will need to be identified before submission by the relevant research offices. If sponsorship remains with the external organisation these costs do not apply. Student projects unless they are MHRA approved trials Small projects less than 20,000 Studies where application of the sponsorship fee takes the funds requested above the maximum limit for funding Studies that are already funded or where the application was submitted prior to 1 July 2013 Studies where the sponsorship costs were included in the application but the funding body does not award those costs as agreed during contract negotiation Projects applying to an AMRC charity for funding are exempt from the following sponsorship fees: 1) regulatory preparation, 2) trial fees and 3) pharmacovigilance. All other sponsorship fees apply (see section 3, page 2). Version 2.0/August 2014/Page 7 of 7
STANDARD OPERATING PROCEDURE. Risk Assessment of STH sponsored CTIMPs
Research Department STANDARD OPERATING PROCEDURE of STH sponsored CTIMPs SOP History None SOP Number C118 Created STH Research Department (EW) Reviewed STH Research Department (EW) Superseded Version 1.0,
More informationAttributing the costs of health and social care Research & Development (AcoRD)
Frequently Asked Questions Annex B Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs, NHS Support Costs
More informationDocument Title: Trust Approval and Research Governance
Document Title: Trust Approval and Research Governance Document Number: SOP034 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationSummary of the role and operation of NHS Research Management Offices in England
Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices
More informationQ1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS?
Annex B Frequently Asked Questions Updated May 2015 Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs,
More informationAttributing the costs of health & social care Research & Development Understanding AcoRD
Attributing the costs of health & social care Research & Development Understanding AcoRD Trudi Simmons Senior Manager Research Finance & Programmes Trudi.simmons@dh.gsi.gov.uk 1 Implementation Intoduction
More informationAttributing the costs of health and social care Research & Development (AcoRD)
Frequently Asked Questions Updated December 2015 Annex B Contents 1. Introduction... 2 2. Funding sources... 2 3. Clinical Research Network funding... 5 4. Application advice services/nhs permissions...
More informationRESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS. Research Governance Group
RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS Reference No: UHB 074 Version No: 5 Previous Trust / LHB Ref No: N/A Documents to read alongside
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY Policy Title Version: Approved by: Date of approval: 29 June 2015 Policy supersedes: Lead Board Director: Policy Lead (and author if different): Name of responsible committee/group:
More informationUNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)
More informationSOP Number: SOP-QA-34 Version No: 1. Version Description of Changes Date Effective. Change of number for Q-Pulse (Replaces UoA-NHSG-SOP-051 V1)
Standard Operating Procedure: SOP Number: SOP-QA-34 Version No: 1 Author: Date: 1-9-15 (Carole Edwards, Lead Research Nurse, NHS Grampian) Approved by: Date: 1-9-15 (Professor Julie Brittenden, R&D Director,
More informationDocument Title: Project Management of Papworth Sponsored Studies
Document Title: Project Management of Papworth Sponsored Studies Document Number: SOP009 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G
More informationArchiving of Research Documentation
Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment
More informationTRIAL MASTER FILE- SPONSORED
gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER
More informationSOP Number: SOP-QA-20 Version No: 1. Author: Date: 1-9-15 (Patricia Burns, Research Governance Manager, University of Aberdeen)
Standard Operating Procedure: SOP Number: SOP-QA-20 Version No: 1 Author: Date: 1-9-15 (Patricia Burns, Research Governance Manager, University of Aberdeen) Approved by: Date: 1-9-15 (Professor Julie Brittenden,
More informationGuidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1)
Guidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1) What is the HRA Statement of Activities? The Statement of Activities is part of the application
More informationResearch funding applications involving Cardiff & Vale UHB. Emma Lewis R&D Coordinator. Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a r Fro
Research funding applications involving Cardiff & Vale UHB Emma Lewis R&D Coordinator Objectives R&D review of grant applications Identifying resources required for your project Attributing costs using
More informationAttributing the costs of health and social care Research and Development (AcoRD)
Attributing the costs of health and social care Research and Development (AcoRD) Page 1 of 8 Contents Contents. 2 Purpose.. 3 Background. 3 Basic Principles.. 4 Commercial Contract Studies.. 4 Non-commercial
More informationManaging & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
More informationMarie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager
Standard Operating Procedures (SOP) for: Monitoring SOP 28 Version 7.0 Number: Number: Effective Date: 29 th November 2015 Review Date: 6 th January 2017 Author: Reviewer: Reviewer: Authorisation: Name
More informationgsop-32-02 - Vendor Assessment SOP page 1 of 10
gsop-32-02 - Vendor Assessment SOP page 1 of 10 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust VENDOR ASSESSMENT Research & Development
More informationTrial Delivery SOP 05 Trial Archiving
Gloucestershire Research and Development Consortium Standard Operating Procedure R&D SOP TD 05Trial Archiving Trial Delivery SOP 05 Trial Archiving IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO
More informationStudy-wide considerations: identifies the areas of the criterion the lead reviewer should consider when conducting the review
UK STUDY-WIDE GOVERNANCE CRITERIA FOR R&D REVIEW INTRODUCTION The following document is intended to provide operational guidance to the person taking the UK lead in conducting the R&D Study-Wide review
More informationDorset Research Consortium. Research Governance: A handbook for Researchers in Dorset
Dorset Research Consortium Research Governance: A handbook for Researchers in Dorset DRC Version 1 dated 25 th July 2012 Research Governance: The Basics... 4 What is Research Governance?... 4 The Research
More informationDATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS
Reference Number: UHB 139 Version Number: 2 Date of Next Review: 14 Apr 2018 Previous Trust/LHB Reference Number: N/A DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS Introduction and Aim
More informationPolicy Flowchart. Policy Title: Research Governance, Conduct and Management Policy. Reference and Version No: IG6 Version 5
Policy Title: Research Governance, Conduct and Management Policy Reference and Version No: IG6 Version 5 Author and Job Title: J Greenaway Research and Development Manager Executive Lead Medical Director
More informationGood Clinical Practice (GCP)
Good Clinical Practice (GCP) Joanne Thompson Clinical Trials Monitor and Trainer, UHL Dec 2011 1 1 What is GCP? An international ethical and scientific quality standard for designing, conducting, recording
More informationStandard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL
Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,
More informationAn introduction to Research Management and Governance (RM&G) in the NHS
An introduction to Research Management and Governance (RM&G) in the NHS Rachel Davis Assistant RM&G Project Manager Natassia Embury R&D Facilitator 14/04/2014 Delivering clinical research to make patients,
More informationJoint Research Office
Office Location: 1 st Floor Maple House 149 Tottenham Court Road London W1T 7DN Joint Research Office Postal Address: UCL, Gower Street London WC1E 6BT Email: hameedah.bogle-dawoud@nhs.net Tel No. 020
More informationThis document explains the main differences between two sets of performance metrics:
Document Version 2.0 Date November 2013 The (70 day benchmark) and the NIHR Clinical Research Network High Level Objectives: a description of purpose, definition and differences Introduction This document
More informationNORWICH CLINICAL TRIALS UNIT OVERVIEW
NORWICH CLINICAL TRIALS UNIT OVERVIEW This document provides an overview of the Norwich Clinical Trials Unit. Sections 1 to 3 describe the Norwich Clinical Trials Unit remit and structure. Section 4 gives
More informationDepartment of Health - Research Governance Framework (RGF)
LIVERPOOL JOHN MOORES UNIVERSITY SPONSORSHIP OF RESEARCH PROJECTS UNDER THE RESEARCH GOVERNANCE FRAMEWORK FOR HEALTH AND SOCIAL CARE April 2015 1 Background The Department of Health s Research Governance
More informationDocument Title: Research Database Application (ReDA)
Document Title: Research Database Application (ReDA) Document Number: SOP035 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationThe people needed to complete the costs for a funding application are:
Research Design Service London Guide to costing grant applications The people needed to complete the costs for a funding application are: The chief investigators and or senior researchers Your local Trust,
More informationThis SOP may also be used by staff from other NHS areas, or organisations, with prior agreement.
Standard Operating Procedure: SOP Number: SOP-QA-32 Version No: 1 Author: Date: (Gary Cooper, Named Sponsor Archivist, NHS Grampian and University of Aberdeen) 1-9-15 Approved by: Date: 1-9-15 (Professor
More informationTEMPLATE DATA MANAGEMENT PLAN
TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager
More informationTrust/Host Site Approval. Presented by: Anika Kadchha Research Governance Officer
Trust/Host Site Approval Presented by: Anika Kadchha Research Governance Officer Joint Research & Enterprise Office Training 19 th January Outline What is Research NHS Ethics (if required) Host Site Approval
More informationIntroduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6
Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication
More informationPERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIALS DATA RECORD ADJUSTMENT PROCESS
PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIALS DATA RECORD ADJUSTMENT PROCESS Version Control Amended small error in Acronyms table (page 2) 1 Acronyms CTP FPR MHRA REC SOP TMB VRA Clinical
More informationROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
More informationAttributing the costs of Health and Social Care Research & Development (AcoRD)
HSC R&D Division Attributing the costs of Health and Social Care Research & Development (AcoRD) Contents Contents... 2 Purpose... 3 Background... 3 Basic Principles...4 Commercial Contract Studies...4-5
More informationSTANDARD OPERATING PROCEDURE FOR RESEARCH. 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol
Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Undertaking Risk Assessment of a Research and Development Project SOP Number: 33 Version Number: 1.0 Supercedes: N/A Effective
More informationWhat is necessary to provide good clinical data for a clinical trial?
What is necessary to provide good clinical data for a clinical trial? Alain Barrois, Assistant Clinical Trials Operations Manager #EBMT2015 www.ebmt.org Is this a (typical) clinical trial? 2 Agenda Introduction
More informationSection 5 onwards provides information aimed at researchers who are interested in working with us.
NORWICH CLINICAL TRIALS UNIT This document provides an overview of the Norwich Clinical Trials Unit: Sections 1 to 3 describe the Norwich Clinical Trials Unit remit and structure for our stakeholders and
More informationThe Health Research Authority. Janet Wisely. April 2015
The Health Research Authority Janet Wisely April 2015 The HRA as an organisation A Non-Departmental Public Body January 2015 Public sector employees on NHS terms Volunteer members of committees A Special
More informationR&D Administration Manager. Research and Development. Research and Development
Document Title: Document Number: Patient Recruitment SOP031 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D Administration Manager,
More informationCONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator
Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley
More informationNAVIGATING ETHICAL APPROVAL AND ACCESS IN SOCIAL CARE RESEARCH
NAVIGATING ETHICAL APPROVAL AND ACCESS IN SOCIAL CARE RESEARCH January 2014 Preamble This document has been produced by the Scottish Government, the Association of Directors of Social Work (ADSW) and the
More informationCRN: South London Funding Model
Summary of Partnership Group Agreement to Clinical Research Network: South London Funding Model Proposal 1. Introduction The Clinical Research Network: South London (CRN: South London) was formed in April
More informationEU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
More informationDate Ratified 03/12/2012 Human Resources Committee Review Date 01/12/2014 Director of Finance and Information Expiry Date 02/12/2015 Withdrawn Date
Policy No: OP7 Version: 4.0 Name of Policy: Submission of Staff Expenses Policy Effective From: 18/12/2012 Date Ratified 03/12/2012 Ratified Human Resources Committee Review Date 01/12/2014 Sponsor Director
More informationResearch Study Close-down and Archiving Procedures
Title: Outcome Statement: Research Study Close-down and Archiving Procedures To inform researchers of the process for closing down research studies, retaining and storing research materials in the Trust.
More informationPrinciple Investigator Training
Principle Investigator Training January 2015, Southampton Dr Waquas Waheed CRN and The University of Manchester Outline Introduction to clinical trials in the UK Role of the networks Role of CSO Role of
More informationEssential Documentation and the Creation and Maintenance of Trial Master Files
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationNational Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CRN Website for the latest version. Version: 6.0 Status: Consultation in
More informationThe EU Clinical Trial Regulation A regulator s perspective
5 The EU Clinical Trial A regulator s perspective Author Martyn Ward, Group Manager, Licensing, Medicines and Healthcare products Regulatory Agency (MHRA), UK. Keywords Clinical Trial Directive (the Directive);
More informationNIHR Guideline B01 Research & Development Operational Capability Statement V 5 2015-16 Updated March 20145
NIHR Guideline B01 Research & Development Operational Capability Statement V 5 2015-16 Updated March 20145 Version History Version number Valid from Valid to Date approved Approved by Updated by RDOCS
More informationAttributing the costs of health and social care Research and Development (AcoRD)
Frequently Asked Questions Annex B - Scotland Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs, NHS
More informationResearch & Development Directorate
Research & Development Directorate Type of Document Standard Operating Procedure Name SOP10: Routine Audit Version 3.0 Author Miss Jennifer Boyle (Research Governance Co-ordinator) Version Superseded 2.4
More informationUK policy framework for health and social care research. Issued for public consultation
UK policy framework for health and social care research Issued for public consultation Introduction and background 1. Context... 1 2. Purpose... 2 3. Scope... 3 4. Implementation... 4 5. UK-wide responsibilities...
More informationCLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
More informationCONFERENCE PLANNING ebook How to organize a research conference your delegates will love
CONFERENCE PLANNING ebook How to organize a research conference your delegates will love Ex Ordo - Phone: +353 (91) 394 545 - info@exordo.com - www.exordo.com Research Conference Planner A research conference
More informationStandard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager
Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s Author: Lisa Austin, Research Manager Purpose and Objective: To identify and standardise
More informationCompetency Framework for Non-Clinical Research Staff
Birmingham and the Black Country Comprehensive Local Research Network Greater Midlands Cancer Research Network Pan Birmingham Cancer Research Network Competency Framework for Non-Clinical Research Staff
More informationInsurance and compensation in the event of injury in Phase I clinical trials
Insurance and compensation in the event of injury in Phase I clinical trials Guidance developed by the Association for the British Pharmaceutical Industry, the BioIndustry Association and the Clinical
More informationThe Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
More informationThe Practicalities of Data Standards
The Practicalities of Data Standards Provided by Catherine Carpenter-Clawson, Research Network Manager For EDGE User Conference 2014 17 th March 2014 Contents Example 1: Local challenges with study arm
More informationNew Methodology to Calculate Funding Levies for Retail Intermediaries. New Methodology to Calculate Funding Levies. for Retail Intermediaries
2016 1 New Methodology to Calculate Funding Levies for Retail Intermediaries Consultation Paper CP 102 New Methodology to Calculate Funding Levies for Retail Intermediaries 1 Contents Page 1. Objective
More informationCHILDREN AND ADULTS SERVICE RESEARCH APPROVAL GROUP
DURHAM COUNTY COUNCIL CHILDREN AND ADULTS SERVICE RESEARCH APPROVAL GROUP INFORMATION PACK Children and Adults Service Version 4 October 2015 Children and Adults Service Research Approval Group Page 1
More informationR&D Fund Reference Document. Supporting market-led innovation in manufacturing and internationally traded services companies.
R&D Fund Reference Document Supporting market-led innovation in manufacturing and internationally traded services companies. Revision date: 28th April 2016 http://www.enterprise-ireland.com/randd 1 Reference
More informationThe Government plan for a secure data service
The Government plan for a secure data service Strengthening the international competitiveness of UK life 1 The Government plan for a secure data service: Strengthening the international competitiveness
More informationResearch & Development Guidance for Students
Research & Development Guidance for Students 2 Contents Introduction 3 Understanding the Research Approval Process 3 Is My Project Audit, Research or Something Else 4 What Next? 4 R&D Step by step Guide
More informationSerious Breaches. Ian Gravenor. Senior Clinical Project Manager Novo Nordisk Ltd
Serious Breaches Ian Gravenor Senior Clinical Project Manager Novo Nordisk Ltd Serious Breaches of GCP or the Trial Protocol Agenda Why report? The legislation MHRA Guidance document Timelines Actions
More informationIntellectual Property Management Policy
Intellectual Property Management Policy Executive or Associate Director lead Policy author/ lead Feedback on implementation to Clive Clarke Ken Lawrie/Karen Robinson Business Planning Group Date of draft
More informationRegulatory Impact Assessment (RIA) Date: /08/15 Type of measure: Subordinate Legislation Lead department or agency: Department for Social Development
Title: Charities accounts: independent examination and audit thresholds Regulatory Impact Assessment (RIA) Date: /08/15 Type of measure: Subordinate Legislation Lead department or agency: Department for
More informationM a r k e t i n g. About managing the doing of marketing for management roles
Professional Diploma in M a r k e t i n g About managing the doing of marketing for management roles Fully sponsored by the HRD Fund for Banking & Financial Sector employees only Professional Diploma in
More informationWe released this document in response to a Freedom of Information request. Over time it may become out of date. Department for Work and Pensions
We released this document in response to a Freedom of Information request. Over time it may become out of date. Department for Work and Pensions 1. Change Control Principles Schedule 24: Change Control
More informationPOLICY FOR MANAGING THE BOUNDARIES OF NHS AND PRIVATE FUNDED HEALTHCARE DOCUMENT CONTROL
POLICY FOR MANAGING THE BOUNDARIES OF NHS AND PRIVATE FUNDED HEALTHCARE DOCUMENT CONTROL TITLE Managing the boundaries of NHS and private funded healthcare AUTHOR Head of Medicines Management VERSION NUMBER
More information2015 National NHS staff survey. Brief summary of results from University College London Hospitals NHS Foundation Trust
2015 National NHS staff survey Brief summary of results from University College London Hospitals NHS Foundation Trust Table of Contents 1: Introduction to this report 3 2: Overall indicator of staff engagement
More informationJRO RMG RSS SOP 12. Standard Operating Procedure (SOP) for Study Closedown and Archiving Royal Free site specific SOP
Office Location: 1 st Floor Maple House 149 Tottenham Court Road London W1T 7DN Joint Research Office Tel No. 0845 1555 000 Web-sites: www.uclh.nhs.uk; www.ucl.ac.uk/jro Postal Address: UCL, Gower Street
More informationResearch is everybody s business
Research and Development Strategy (DRAFT) 2013-2018 Research is everybody s business 1 Information Reader Box to be inserted for documents six pages and over. (To be inserted in final version, after consultation
More informationPHV- 4 version 1 ELECTRONIC ADVERSE DRUG REACTION REPORTING
PHV- 4 version 1 ELECTRONIC ADVERSE DRUG REACTION REPORTING This guideline supersedes guideline PHV 4 as of September 16 2008. 1. Introduction and general provisions 1.1 Purpose of the guideline The guideline
More informationCONTROLLED DOCUMENT. Uncontrolled Copy. RDS014 Research Related Archiving. University Hospitals Birmingham NHS Foundation Trust
University Hospitals Birmingham NHS Foundation Trust CONTROLLED DOCUMENT RDS014 Research Related Archiving CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 1 Controlled Document
More informationPAY POLICY STATEMENT 2015/16
PAY POLICY STATEMENT 2015/16 This Pay Policy Statement is produced in accordance with Chapter 8 of the Localism Act 2011. It was approved by Luton Borough Council ( the Council ) at a meeting of the Full
More informationChemicals and Life Sciences Industry Practice. Insurance and compensation in the event of injury in Phase I clinical trials in the United Kingdom
Chemicals and Life Sciences Industry Practice Insurance and compensation in the event of injury in Phase I clinical trials in the United Kingdom i Insurance and compensation in the event of injury in Phase
More informationRD SOP17 Research data management and security
RD SOP17 Research data management and security Version Number: V2 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive lead: Medical Director
More informationInformation Governance Strategy. Version No 2.1
Livewell Southwest Information Governance Strategy Version No 2.1 Notice to staff using a paper copy of this guidance. The policies and procedures page of LSW Intranet holds the most recent version of
More information1. Trustees annual report
1. Trustees annual report Accounting and reporting by charities Overview and the purpose of the trustees annual report 1.1. The primary purpose of the trustees annual report (the report) is to ensure that
More informationUoM/Archiving/SOP20/2.0
Standard Operating Procedure Number: Title: UoM/Archiving/SOP20/2.0 Preparation, review and issue of SOPs Version: 2.0 () Effective Date Author: Mr Alan Carter Review Date January 2015 Reviewed by : Prof
More informationResearch governance policy
Research governance policy Responsible Officer Author Ben Bennett, Business Planning & Resources Director Sarah Garner, Associate Director, Science Policy & Research Programme Date effective from July
More informationP1415-956. Research Integrity. A Policy Framework on Research Ethics & Governance
P1415-956 Research Integrity A Policy Framework on Research Ethics & Governance CONTENTS Section Topic Pages Forward by Pro Vice Chancellor 4 Scope 5 Executive Summary 6 1 Introduction 7 2 Responsibility
More informationV1.0 - Eurojuris ISO 9001:2008 Certified
Risk Management Manual V1.0 - Eurojuris ISO 9001:2008 Certified Section Page No 1 An Introduction to Risk Management 1-2 2 The Framework of Risk Management 3-6 3 Identification of Risks 7-8 4 Evaluation
More informationEXTENSION OF THE RTA PI SCHEME: PROPOSALS ON FIXED RECOVERABLE COSTS RESPONSE BY THE LAW SOCIETY OF ENGLAND AND WALES
EXTENSION OF THE RTA PI SCHEME: PROPOSALS ON FIXED RECOVERABLE COSTS RESPONSE BY THE LAW SOCIETY OF ENGLAND AND WALES 4 th January 2013 INDEX 1 INTRODUCTION Page No. A Background 1 B Referral fees 2 C
More informationThe European regulatory system for medicines and the European Medicines Agency
The European regulatory system for medicines and the European Medicines Agency A consistent approach to medicines regulation across the European Union An agency of the European Union This booklet is intended
More informationProject Management Assessment Overview
Project Management Assessment Overview Goals The goals of the assessment are to: Provide a self assessment of your company skills in nine areas of project management (e.g. Risk Management, Scope Management,
More informationSCHOOL OF MEDICINE OFFICE OF RESEARCH ADMINISTRATION
SCHOOL OF MEDICINE OFFICE OF RESEARCH ADMINISTRATION Step By Step Guide for: Coeus Proposal Development (Coeus PD) (in place of eis) for Paper (Hard) Copy and Electronic (non Grants.gov) submission Effective
More informationProcurement Policy Note Supporting Apprenticeships and Skills Through Public Procurement
Procurement Policy Note Supporting Apprenticeships and Skills Through Public Procurement Action Note 14/15 27 August 2015 Issue 1. Raising skills levels within the UK workforce is key to delivering sustainable
More informationJoint Strategic Needs Assessment Draft Project Initiation Document
Draft Project Initiation Document Approved by: < Enter name> Date: < DD: MM: YY> Author: Rebecca Brown, Projects and Information Officer Project Initiation Document History Revision History Revision Version
More information